Dynamic Center
In the first half of 2024, 21 new Class 1 drugs were approved by the Food and Drug Administration (FDA) and 26 new Class 1 drugs were approved by Chinese National Medical Products Administration (NMPA). This ar...
[View details]
Developing a photo-affinity probe PAL-CGA revealed ACAT1 as CGA’s key target,and demonstrated CGA inhibits cancer proliferation by blocking ACAT1’s Y407 phosphorylation, highlighting its clinical potential in c...
[View details]
As immune checkpoint inhibitors have shown good clinical efficacy, immune checkpoint blockade has become a vital strategy in cancer therapy. However, approximately only 12.5% patients experience benefits from i...
[View details]
Background: Chlorogenic acid (CHA) has been shown to have substantial biological activities, including anti-inflammatory, antioxidant, and antitumor has not yet been assessed. Neuroblastoma is a type of cancer ...
[View details]
